Navigation Links
PharMEDium Announces Electronic 222 Ordering Initiative
Date:12/3/2007

FIRST AMONG PHARMACY COMPOUNDERS; ENABLES CONVENIENT, SECURE, VIRTUALLY

REAL-TIME ORDERING OF CLASS II CONTROLLED SUBSTANCES

LAKE FOREST, Ill., Dec. 3 /PRNewswire/ -- PharMEDium Services, LLC, the leading provider of outsourced hospital compounded sterile preparations, announced a first-in-the-industry electronic 222 controlled substance ordering system for its entire line of Schedule II Controlled Substances. The initiative will be launched in beta-site form during the month of December, said David Jonas, PharMEDium Chairman and Chief Executive Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051202/PHARMEDIUMLOGO)

The company's investment in e-222 is consistent with its strong commitment to patient safety, quality, and superior customer service, and aligns with moves by the U.S. Drug Enforcement Administration (DEA) and drug/pharmacy industry leaders to use e-commerce to expedite ordering and reduce errors and rework, Jonas said.

The Drug Enforcement Administration (DEA) Office of Diversion Control (ODC) requires a form 222 for all orders of Schedule II Controlled Substances. Until 2005, these orders were processed only via paper forms, which take about 20 minutes to complete. DEA processes about 5.5 million 222 forms yearly, but the drug industry, notably drug distributors, has rapidly upped electronic orders since the agency's Controlled Substances Ordering System (CSOS) was launched in August 2005. Through July 2007, DEA had processed more than three million electronic CSOS orders since the system went into place, with the typical transaction lasting less than 20 seconds, according to the ODC. DEA estimates that the average electronic 222 form costs $6 to process, as opposed to $39 for a paper form.

"The compounding industry has an important role in enhancing quality and improving the healthcare system as a whole, and this initiative will contribute strongly to that effort," said PharMEDium President Rich Kruzynski, R.Ph. "We look forward to making a significant contribution, and to leading our industry down the path of electronic 222 ordering."

About PharMEDium Services, LLC

For more than 15 years, PharMEDium has been the leading provider of outsourced compounding services. In that time, PharMEDium has grown into a nationwide network of state licensed and federally registered compounding centers providing trusted solutions to more than 1,800 hospitals throughout the United States. Managed by licensed pharmacists and staffed by certified technicians, the company complies with all applicable state laws and FDA regulations, including USP Chapter < 797 >, as well as DEA and cGMP Requirements.


'/>"/>
SOURCE PharMEDium Services, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that ... eastern Texas, is announcing the launch of a new charity drive to benefit women ... the United States reveal that an estimated 252, 710 new cases of invasive or ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered in ... balancing their clients’ risk while tailoring optimized benefit packages that strengthen the relationship ...
(Date:6/22/2017)... MN (PRWEB) , ... June 22, 2017 , ... ... the world, announced today that it has received certification for ANSI/ASIS PSC.1-2012. The ... often occurs in environments where the rule of law has been degraded. The ...
(Date:6/20/2017)... ... June 20, 2017 , ... United Benefit Advisors (UBA), the ... Awards (pronounced you-bee) for 2017. The award honors Partner Firms, Principals, agency ... UBA, the clients they serve, and the benefits insurance industry as a whole. ...
(Date:6/20/2017)... ... June 20, 2017 , ... Kenneth Mayer, MD, has been ... (JIAS). , Dr. Mayer, who joined the JIAS Editorial Board in 2016, has co-authored ... Research Director of Fenway Health and Co-Chair of The Fenway Institute, a ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 More than 400 ... effort to help spread lessons learned from clinical research ... Diabetes Federation (IDF) and Eli Lilly and Company (NYSE: ... second phase of the Bringing Research in Diabetes to ... commitment to helping people with diabetes effectively manage their ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/5/2017)... OMAHA, Neb. , June 5, 2017 /PRNewswire/ ... chair in the United States ... chair that helps a fallen person up to an ... is easily assembled and operated by one assistant and ... hand. It is simple enough that a child can ...
Breaking Medicine Technology: